Arrowhead Electronic Healthcare, LLC Selected for eDiary Studies Involving 5000+ Patients

AUSTIN, Texas--(BUSINESS WIRE)--Arrowhead Electronic Healthcare, LLC announced today that 2^nd quarter global sales bookings included studies with 5000+ patients in North America, Latin America and Europe. Based on year to date results, management is confident the company will realize double digit revenue growth for an 8^th consecutive year.

Other developments for Arrowhead in the 2^nd quarter include:

• Celebrated the one year anniversary of its tablet sized eDiary.
• Added new functionality to its proprietary “Dumb Monkey” automated testing and documentation suite for eDiaries.
• Expanded service capabilities in the Middle East through partnership with a telecommunications vendor.
• Extended medication management capabilities by adding a ruggedized solution for SDIO barcode scanners and a separate integrated PDA / scanner option.
• Delivered eDiary services for projects in 23 different countries and 18 different languages.

Arrowhead’s President and CEO Jeff Albrecht said, “Our second quarter results have put us in good position to grow revenues for an 8^th consecutive year. This is a superb testament to the effectiveness of the Arrowhead team and the value we are delivering to customers. We are especially pleased to be helping customers who have previously had poor experiences with other eDiaries and who appreciate reliability improvements from ePRO-LOG in key areas such as usability, remote data transmission, software configuration and customer support.”

About Arrowhead Electronic Healthcare, LLC

Arrowhead Electronic Healthcare, LLC is the global market leader in eDiary reliability engineering. Since 1999, Arrowhead has been improving the delivery of healthcare around the world by helping pharmaceutical research and marketing organizations document important information directly from patients’ homes about medication administration, efficacy, safety, and cost effectiveness. This includes the collection of patient reported outcomes during clinical trials, post-marketing studies and treatment optimization programs. To learn more, visit www.aheh.com.